Jane Street’s EyePoint Pharmaceuticals EYPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$148K Buy
+15,720
New +$148K ﹤0.01% 4875
2025
Q1
Sell
-20,482
Closed -$153K 5850
2024
Q4
$153K Sell
20,482
-22,104
-52% -$165K ﹤0.01% 5209
2024
Q3
$340K Sell
42,586
-59,201
-58% -$473K ﹤0.01% 4732
2024
Q2
$886K Sell
101,787
-112,907
-53% -$982K ﹤0.01% 3831
2024
Q1
$4.44M Buy
214,694
+144,799
+207% +$2.99M ﹤0.01% 1413
2023
Q4
$1.62M Buy
69,895
+39,672
+131% +$917K ﹤0.01% 2757
2023
Q3
$241K Buy
30,223
+17,068
+130% +$136K ﹤0.01% 4249
2023
Q2
$114K Buy
+13,155
New +$114K ﹤0.01% 4760
2022
Q4
Sell
-20,720
Closed -$164K 5699
2022
Q3
$164K Buy
+20,720
New +$164K ﹤0.01% 4693
2022
Q2
Sell
-13,881
Closed -$169K 5734
2022
Q1
$169K Buy
13,881
+3,113
+29% +$37.9K ﹤0.01% 4784
2021
Q4
$132K Buy
+10,768
New +$132K ﹤0.01% 4567
2020
Q4
Sell
-9,231
Closed -$48K 4005
2020
Q3
$48K Sell
9,231
-34,440
-79% -$179K ﹤0.01% 3576
2020
Q2
$331K Buy
+43,671
New +$331K ﹤0.01% 2940
2019
Q3
Sell
-20,258
Closed -$332K 3572
2019
Q2
$332K Buy
20,258
+19,122
+1,683% +$313K ﹤0.01% 2639
2019
Q1
$20K Buy
+1,136
New +$20K ﹤0.01% 3213
2018
Q3
Sell
-4,434
Closed -$92K 3582
2018
Q2
$92K Buy
+4,434
New +$92K ﹤0.01% 3066
2016
Q1
Sell
-1,714
Closed -$83K 2675
2015
Q4
$83K Buy
+1,714
New +$83K ﹤0.01% 2493
2014
Q4
Sell
-2,198
Closed -$97K 1959
2014
Q3
$97K Sell
2,198
-12,234
-85% -$540K ﹤0.01% 2023
2014
Q2
$626K Buy
14,432
+866
+6% +$37.6K 0.01% 1014
2014
Q1
$556K Sell
13,566
-1,380
-9% -$56.6K 0.01% 1250
2013
Q4
$593K Buy
14,946
+13,714
+1,113% +$544K 0.01% 916
2013
Q3
$51K Buy
1,232
+232
+23% +$9.6K ﹤0.01% 2312
2013
Q2
$39K Buy
+1,000
New +$39K ﹤0.01% 2245